New York, Aug. 17, 2023 (GLOBE NEWSWIRE) -- The global revenue from the perfusion bioreactors market is estimated to reach US$ 345.6 Million in 2022, with the global market growing at a 7.2% CAGR to ...
Dublin, Oct. 09, 2025 (GLOBE NEWSWIRE) -- The "Perfusion Bioreactors Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product ...
Recombinant adeno-associated virus (rAAV) is currently used as vector in about 250 clinical trials for gene therapy (Bulcha et al., 2021). Nonetheless, there are still several challenges concerning ...
The demand for producing therapeutic recombinant proteins is generating a renewed interest in perfusion cell culture technologies, leading to the development of cell culture media that can support ...
As GEN readers are well aware, single-use bioreactors (SUBs)—already accepted at research scale for screening and optimization, as well as at pilot scale and seeding—are now ready for GMP-compliant ...
Fed-batch gives you one data point per sample pull. Perfusion demands continuous, real-time process intelligence, and process analytical technology (PAT) is the only way to deliver it. As ...
The impact of customer-side business trends in the single-use bioreactors market is shaped by changing biomanufacturing priorities, process intensification, and demand for flexible production capacity ...
Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry today announced the launch of the ambr ® 250 high throughput (ht) perfusion, a new automated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results